Tyra Biosciences, Inc. (TYRA)
NASDAQ·Healthcare·Biotechnology
$29.02
+2.84%
Mkt Cap $1.51B
Analyst Ratings
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$50.50
Range $42.00 – $59.00
Implied Upside
+74.0%
Consensus $50.50 vs current $29.02
NASDAQ·Healthcare·Biotechnology
$29.02
+2.84%
Mkt Cap $1.51B
Buy
8
Hold
0
Sell
0
Price Target (15 analysts)
$50.50
Range $42.00 – $59.00
+74.0%
Consensus $50.50 vs current $29.02